| 1/26/2012 |
ELITE PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL APPLICATION FOR HYDROMORPHONE
|
| 1/3/2012 |
ELITE PHARMACEUTICALS SECURES $5 MILLION FUNDING COMMITMENT
|
| 10/19/2011 |
ELITE PHARMACEUTICALS ANNOUNCES RESULTS OF
ANNUAL MEETING OF STOCKHOLDERS
|
| 9/27/2011 |
ELITE PHARMACEUTICALS AND ECR PHARMACEUTICALS LAUNCH
LODRANE D® ALLERGY PRODUCT
|
| 8/16/2011 |
Elite Pharmaceuticals, Inc. Reports Financial Results for the First
Quarter Ended June 30, 2011
Revenues up 19% - Positive Operating Cash Flow – Phentermine Launched
|
